Cipla Q1FY25 Highlights - Umang Vohra, MD & CEO, Cipla, - "A solid foundation laid for fiscal year as we continue to make remarkable progress by deepening our portfolio and creating more value through innovation, particularly in the biotech sector. We accelerated efforts on our growth drivers - #lungleadership, #AMR & #wellness, in addition to charting new frontiers with #obesity and #mentalhealth. Our recognition spree for patient-care and people initiatives shows our passion for care and we hope to keep this momentum in the quarters to come.”